246 related articles for article (PubMed ID: 17009076)
1. Correlations of tissue macrophages and cytoskeletal protein expression with renal fibrosis in patients with diabetes mellitus.
Yonemoto S; Machiguchi T; Nomura K; Minakata T; Nanno M; Yoshida H
Clin Exp Nephrol; 2006 Sep; 10(3):186-92. PubMed ID: 17009076
[TBL] [Abstract][Full Text] [Related]
2. Cytoskeletal protein expression and regenerative markers in schistosomal nephropathy.
El-Koraie AF; Baddour NM; Adam AG; El-Kashef EH; El Nahas AM
Nephrol Dial Transplant; 2002 May; 17(5):803-12. PubMed ID: 11981067
[TBL] [Abstract][Full Text] [Related]
3. Expression of cytoskeletal proteins during the course of experimental diabetic nephropathy.
Sanai T; Sobka T; Johnson T; el-Essawy M; Muchaneta-Kubara EC; Ben Gharbia O; el Oldroyd S; Nahas AM
Diabetologia; 2000 Jan; 43(1):91-100. PubMed ID: 10663221
[TBL] [Abstract][Full Text] [Related]
4. Myofibroblasts and the progression of diabetic nephropathy.
Essawy M; Soylemezoglu O; Muchaneta-Kubara EC; Shortland J; Brown CB; el Nahas AM
Nephrol Dial Transplant; 1997 Jan; 12(1):43-50. PubMed ID: 9027772
[TBL] [Abstract][Full Text] [Related]
5. A morphometric insight into glomerular and interstitial lesions in acutely rejected renal allografts.
Danilewicz M; Wagrowska-Danilewicz M
Pol J Pathol; 2003; 54(3):171-7. PubMed ID: 14703283
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of berberine on renal fibrosis caused by diabetic nephropathy.
Li Z; Zhang W
Mol Med Rep; 2017 Aug; 16(2):1055-1062. PubMed ID: 29067464
[TBL] [Abstract][Full Text] [Related]
7. Diabetic nephropathy, inflammation, hyaluronan and interstitial fibrosis.
Lewis A; Steadman R; Manley P; Craig K; de la Motte C; Hascall V; Phillips AO
Histol Histopathol; 2008 Jun; 23(6):731-9. PubMed ID: 18366011
[TBL] [Abstract][Full Text] [Related]
8. Macrophages in diabetic nephropathy in patients with type 2 diabetes.
Klessens CQF; Zandbergen M; Wolterbeek R; Bruijn JA; Rabelink TJ; Bajema IM; IJpelaar DHT
Nephrol Dial Transplant; 2017 Aug; 32(8):1322-1329. PubMed ID: 27416772
[TBL] [Abstract][Full Text] [Related]
9. The sialoadhesin (CD169) expressing a macrophage subset in human proliferative glomerulonephritis.
Ikezumi Y; Suzuki T; Hayafuji S; Okubo S; Nikolic-Paterson DJ; Kawachi H; Shimizu F; Uchiyama M
Nephrol Dial Transplant; 2005 Dec; 20(12):2704-13. PubMed ID: 16169862
[TBL] [Abstract][Full Text] [Related]
10. The expression of cytoskeletal proteins (alpha-SMA, vimentin, desmin) in kidney tissue: a comparison of fetal, normal kidneys, and glomerulonephritis.
Gonlusen G; Ergin M; Paydaş S; Tunali N
Int Urol Nephrol; 2001; 33(2):299-305. PubMed ID: 12092643
[TBL] [Abstract][Full Text] [Related]
11. Expression of cytoskeletal proteins differentiates between progressors and non-progressors in treated idiopathic membranous nephropathy.
Tamimi NA; Stevens PE; O'Donnell PL; Strange PG; Muchaneta-Kubara EC; El Nahas AM
Exp Nephrol; 1998; 6(3):217-25. PubMed ID: 9639037
[TBL] [Abstract][Full Text] [Related]
12. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes.
Coimbra TM; Janssen U; Gröne HJ; Ostendorf T; Kunter U; Schmidt H; Brabant G; Floege J
Kidney Int; 2000 Jan; 57(1):167-82. PubMed ID: 10620198
[TBL] [Abstract][Full Text] [Related]
13. Wegener's granulomatosis: inflammatory cells and markers of repair and fibrosis in renal biopsies--a clinicopathological study.
Aasarød K; Bostad L; Hammerstrøm J; Jørstad S; Iversen BM
Scand J Urol Nephrol; 2001 Oct; 35(5):401-10. PubMed ID: 11771868
[TBL] [Abstract][Full Text] [Related]
14. Redistribution of connexin43 expression in glomerular podocytes predicts poor renal prognosis in patients with type 2 diabetes and overt nephropathy.
Sawai K; Mukoyama M; Mori K; Yokoi H; Koshikawa M; Yoshioka T; Takeda R; Sugawara A; Kuwahara T; Saleem MA; Ogawa O; Nakao K
Nephrol Dial Transplant; 2006 Sep; 21(9):2472-7. PubMed ID: 16820374
[TBL] [Abstract][Full Text] [Related]
15. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
[TBL] [Abstract][Full Text] [Related]
16. Renal histologic changes and the outcome in patients with diabetic nephropathy.
An Y; Xu F; Le W; Ge Y; Zhou M; Chen H; Zeng C; Zhang H; Liu Z
Nephrol Dial Transplant; 2015 Feb; 30(2):257-66. PubMed ID: 25063425
[TBL] [Abstract][Full Text] [Related]
17. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury.
Chow F; Ozols E; Nikolic-Paterson DJ; Atkins RC; Tesch GH
Kidney Int; 2004 Jan; 65(1):116-28. PubMed ID: 14675042
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of collagen I accumulation reduces glomerulosclerosis by a Hic-5-dependent mechanism in experimental diabetic nephropathy.
Hornigold N; Johnson TS; Huang L; Haylor JL; Griffin M; Mooney A
Lab Invest; 2013 May; 93(5):553-65. PubMed ID: 23508044
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic correlations in lupus nephritis in Lima, Peru.
Hurtado A; Asato C; Escudero E; Stromquist CS; Urcia J; Hurtado ME; de La Cruz S; Wener MH; Zavala R; Johnson RJ
Nephron; 1999; 83(4):323-30. PubMed ID: 10575294
[TBL] [Abstract][Full Text] [Related]
20. Fibrosis and evidence for epithelial-mesenchymal transition in the kidneys of patients with staghorn calculi.
Boonla C; Krieglstein K; Bovornpadungkitti S; Strutz F; Spittau B; Predanon C; Tosukhowong P
BJU Int; 2011 Oct; 108(8):1336-45. PubMed ID: 21410631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
